Dan is the founding member of the Dan family of secreted cytokines. All members of this family ± which includes Gremlin, Cerberus, Dante, PRDC, and several genes identi®ed as expressed sequence tags in the mouse ± characterized to date have been shown to antagonize signaling by the bone morphogenetic protein (BMP) family. During mouse embryogenesis, Dan is expressed in a restricted and dynamic pattern. Major sites of transcription include the somites, the myotome and the cranial, and facial and limb mesenchyme. Xenopus Dan (XDan) shares over 76% amino acid identity with mouse Dan (mDan). Here we report that in Xenopus embryos, XDan is expressed both as a maternal transcript and at later stages in populations of cells associated with the cranial and trunk neural crest. The conservation of Dan expression in cells of the head mesenchyme between Xenopus and mouse embryos suggests an important role for BMP antagonists in these tissues. q
Results and discussion
Dan was initially identi®ed through differential screening as a transcript downregulated in src-transformed rat ®bro-blasts Sakiyama, 1993, 1994) . Sequence analysis subsequently placed Dan into an evolutionarily conserved family of secreted antagonists of bone morphogenetic proteins (BMPs) and other transforming growth factor b (TGFb) proteins (Hsu et al., 1998) . Like other BMP antagonists, Dan can neuralize ectodermal explants from Xenopus embryos and convert ventral mesoderm to more dorsal fates. Dan is also able to bind BMP-2 in vitro directly, although frog embryo assays suggest that it may be a more potent antagonist of the GDF-5/6/7 class of BMPs in vivo (Hsu et al., 1998; Stanley et al., 1998; Pearce et al., 1999; Dionne et al., 2001) .
In the mouse, mDan expression begins at the onset of organogenesis around E8.0 when transcripts are apparent in the newly formed somites and in the head mesenchyme ventral to the midbrain. As development proceeds, mDan continues to be expressed in a dynamic pattern in both nascent and more mature somites. In the head, Dan transcripts are detected in the branchial arches, the edge of the olfactory pit, and in the endoderm of pharyngeal pouches 1 and 2 (Stanley et al., 1998; Pearce et al., 1999) . Mice homozygous for a Dan mutant allele are viable and display no obvious morphological abnormalities, although animals lacking Dan and heterozygous for a Noggin mutation display subtle skeletal defects that are not observed in Dan±Noggin trans-heterozygotes (Dionne et al., 2001 ). This suggests that there may be functional redundancy between multiple TGFb antagonists in some or all of these tissues.
To understand what roles Dan may play in other species, we have analyzed the spatial and temporal expression pattern of XDan during Xenopus embryogenesis by reverse transcriptase polymerase chain reaction (RT-PCR) analysis and whole-mount in situ hybridization. XDan is present in the early embryo as a maternal transcript which begins to decline in abundance at the onset of gastrulation and is completely lost by neurula stages (Fig. 1) . The strong maternal contribution of XDan transcripts in the blastula stage embryo is unique among the Dan family members characterized thus far in Xenopus (Bouwmeester et al., 1996; Hsu et al., 1998) . Whole-mount in situ analysis of stage VI oocytes bisected through the animal±vegetal axis reveals maternal XDan transcripts are localized to the nucleoplasm ( Fig. 2A) . In stage 3 embryos, these transcripts are detected throughout the animal hemisphere (Fig. 2B) . By the end of gastrulation, XDan transcript levels have signi®cantly decreased as indicated by RT-PCR (Fig. 1) and are no longer detected by in situ hybridization (data not shown). Zygotic XDan expression begins around stage 25 as indicated by both RT-PCR and whole-mount in situ analysis (Figs. 1 and 2C,D) . Initially, XDan is expressed in migrating derivatives of the cranial neural crest, with highest levels detected in the mandibular neural crest segment surrounding the eye. Expression is also apparent in cells of the cranial neural crest demarcating the rhombomeres and at the midbrain±hindbrain boundary. Weak expression of XDan is seen throughout the trunk neural crest in two stripes¯ank-ing the dorsal midline and migrating ventrally in distinctive chevron-shaped pathways (Fig. 2C,D) .
By stage 30, XDan is expressed extensively throughout many derivatives of the cranial neural crest. In the head, strong expression is detected in the mandibular, hyoid and branchial arches, the eye vesicle (especially adjacent to the optic ®ssure), the anterior midbrain, the midbrain±hindbrain boundary, and the otic vesicle. Expression also continues throughout the trunk neural crest with highest levels in the premigratory cells of the dorsal neural tube and in cells that have migrated dorsally to form the ®n mesenchyme (Fig.  2E±G ). This pattern of expression continues through stage 38 (Fig. 2I,J) . In horizontal sections (Fig. 2K) , XDan transcripts are found both along the ventricular and pial surfaces of the fore-and midbrain. Both sectioned and whole embryos exhibit strong expression at the lip of the eye vesicle and in derivatives of the mandibular and hyoid arches while weaker staining persists in the branchial arches and the otic vesicle. XDan continues to be associated with cells of the dorsal midline at stage 38 and faint expression is still detectable in the chevrons of migrating neural crest (Fig.  2I,L) . XDan transcripts are detected in a punctate pattern throughout the mesenchyme of the tail®n and in prominent stripes running parallel to the dorsal and ventral edges of the ®n (Fig. 2H ).
Materials and methods

RT-PCR analyses
RT-PCR analysis was performed as described by Wilson and Melton (1994) using total RNA isolated from embryos at the indicated stages. The primers for XDan (U: 5 H -CTCCCAGTGGCGATTTTTGC; D: 5 H -CACAATGGAC-CAACGACTCTGTAG) were annealed at 558C for 25 cycles.
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were carried out according to the method of Harland (1991) with the modi®cations described by Knecht et al. (1995) . Boehringer Mannheim purple AP substrate was used for all staining. Stage VI oocytes and stage 3 embryos were bisected through the animal±vegetal axis prior to in situ hybridization. For histological analysis, stained embryos were embedded in TBS tissue freezing medium (Fisher) and 20-mm sections were cut on a cryotome.
